Related Experiment Video
Updated: Jul 16, 2026

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
Published on: July 21, 2011
The gadolinium complexes with polyoxometalates as potential MRI contrast agents
Zhongfeng Li1, Weisheng Li, Xiaojing Li
1Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, P.R. China.
Two novel gadolinium (Gd) polyoxometalates show promise as tissue-specific MRI contrast agents. These agents exhibit higher relaxivity and favorable in vivo liver enhancement and renal excretion compared to existing contrast agents.
Area of Science:
- Inorganic Chemistry
- Materials Science
- Medical Imaging
Background:
- Gadolinium (Gd) based compounds are widely used as contrast agents in Magnetic Resonance Imaging (MRI).
- Developing novel contrast agents with improved relaxivity and tissue specificity is crucial for enhanced diagnostic capabilities.
- Polyoxometalates offer a versatile platform for designing new Gd-based contrast agents.
Purpose of the Study:
- To evaluate two novel gadolinium polyoxometalates, Gd(BW(11))(2) and Gd(CuW(11))(2), as potential tissue-specific MRI contrast agents.
- To compare their performance against a commercial contrast agent (GdDTPA).
- To assess their in vitro relaxivity and in vivo biodistribution and excretion profiles.
Main Methods:
- Synthesis and characterization of K(15)[Gd(BW(11)O(39))(2)] and K(17)[Gd(CuW(11)O(39))(2)].
- In vitro measurement of T(1) relaxivity in aqueous solutions and biological fluids (bovine serum albumin, human serum transferrin).
- In vivo MRI studies in Wistar rats to assess liver enhancement and renal excretion after intravenous administration.
Main Results:
- Gd(BW(11))(2) and Gd(CuW(11))(2) exhibited significantly higher T(1) relaxivities (17.12 and 19.95 mM(-1)s(-1), respectively) compared to GdDTPA.
- In vivo studies in Wistar rats demonstrated remarkable liver enhancement and favorable renal excretion for both Gd(BW(11))(2) and Gd(CuW(11))(2).
- Specific signal intensity increases were quantified for liver and kidney at defined time points and doses.
Conclusions:
- Gd(BW(11))(2) and Gd(CuW(11))(2) are promising candidates for developing advanced, tissue-specific MRI contrast agents.
- Their superior relaxivity and favorable in vivo performance suggest potential for improved diagnostic accuracy in MRI.
- Further research may explore their clinical translation for enhanced medical imaging.
Related Concept Videos
Complexometric Titration: Ligands
Colors and Magnetism
When atoms or molecules absorb light at the proper frequency, their electrons are excited to higher-energy orbitals. For many main group atoms and molecules, the absorbed photons are in the ultraviolet range of the electromagnetic spectrum, which cannot be detected by the human eye. For coordination compounds, the energy difference between the d orbitals often allows photons in the visible range to be absorbed and emitted, which is seen as colors by the human eye.
Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
EDTA: Chemistry and Properties
Complexation Equilibria: The Chelate Effect

